PBSC collection from family donors in Japan: a prospective survey
Open Access
- 30 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 49 (2), 195-200
- https://doi.org/10.1038/bmt.2013.147
Abstract
Severe adverse events (SAE) and late hematological malignancies have been reported after PBSC donation. No prospective data on incidence and risk factors have been available for family donors so far. The Japan Society for Hematopoietic Cell Transplantation (JSHCT) introduced therefore in 2000 a mandatory registration system. It defined standards for donor eligibility and asked harvest centers to report any SAE immediately. All donors were examined at day 30 and were to be contacted once each year for a period of 5 years. Acute SAEs within day 30 were reported from 47/3264 donations (1.44%) with 14 events considered as unexpected and severe (0.58%). No donor died within 30 days. Late SAEs were reported from 39/1708 donors (2.3%). The incidence of acute SAEs was significantly higher among donors not matching the JSHCT standards (P=0.0023). Late hematological malignancies in PBSC donors were not different compared with a retrospective cohort of BM donors (N:1/1708 vs N:2/5921; P=0.53). In conclusion, acute and late SAEs do occur in PBSC donors at relatively low frequency but risk factors can be defined.Keywords
This publication has 42 references indexed in Scilit:
- Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)Bone Marrow Transplantation, 2012
- Can G-CSF Cause Leukemia in Hematopoietic Stem Cell Donors?Transplantation and Cellular Therapy, 2011
- WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation1Transplantation, 2010
- Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donorsBlood, 2009
- Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramBlood, 2009
- Severe events in donors after allogeneic hematopoietic stem cell donationHaematologica, 2009
- Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor RegistryHaematologica, 2008
- Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) projectBritish Journal of Haematology, 2006
- Healthy sibling donation of G‐CSF primed stem cells: A call for researchPediatric Blood & Cancer, 2006
- Ethical DilemmasBone Marrow Transplantation, 1999